Our Pricing

Wegovy Injection UK - All Doses In Stock & Ready to Ship

Finding wegovy injection uk in stock across all dose strengths can be challenging during ongoing supply constraints. At Cured Pharmacy, we maintain consistent availability of every Wegovy dose — from 0.25mg starter pens through to the 2.4mg maintenance dose — with transparent pricing from £79.00 and next-day discreet delivery across the UK.

How Wegovy Semaglutide Works for Weight Loss

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or above, or 27 kg/m² with weight-related comorbidities [1]. Semaglutide mimics the natural GLP-1 hormone your body produces after eating, which regulates appetite and food intake through multiple pathways in the brain and digestive system.

In the landmark STEP 1 trial involving 1,961 adults, participants receiving once-weekly semaglutide 2.4mg achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. Beyond appetite suppression, semaglutide slows gastric emptying and enhances insulin secretion, creating a comprehensive metabolic effect that supports sustainable weight reduction when combined with lifestyle modifications.

Our superintendent pharmacist Tarun Kumar (GPhC 2233073) reviews every Wegovy prescription to ensure appropriate dosing escalation and monitoring, particularly during the critical first 16 weeks when patients transition through lower doses to minimise gastrointestinal side effects.

Wegovy Dosing Schedule: Complete UK Guide

Wegovy follows a structured dose-escalation protocol designed to improve gastrointestinal tolerability whilst building therapeutic efficacy. The standard UK dosing schedule begins with 0.25mg once weekly for four weeks, then increases monthly through 0.5mg, 1mg, and 1.7mg doses before reaching the 2.4mg maintenance dose at week 17 [2].

This gradual titration is clinically essential — patients who escalate too rapidly experience significantly higher rates of nausea, vomiting, and treatment discontinuation. Each dose strength comes in pre-filled, single-use injection pens with hidden needles for ease of use, and all doses are currently in stock at Cured Pharmacy with pricing from £79.00.

If you miss a dose and your next scheduled injection is more than two days away, take the missed dose as soon as possible. If less than two days remain until your next dose, skip the missed dose entirely and resume your regular schedule [2]. Never double doses to compensate for missed injections.

When to Adjust Your Wegovy Dose

Your UK prescriber may recommend delaying dose escalation if you experience persistent nausea, vomiting, or diarrhoea during any titration phase. Clinical guidance suggests remaining at your current dose for an additional four weeks can improve tolerance before advancing. Conversely, if you reach the 2.4mg maintenance dose but haven't achieved at least 5% body weight reduction after 16 weeks on the maximum dose, NICE guidance recommends reviewing treatment continuation with your healthcare provider [3].

Wegovy Injection UK In Stock: Addressing Supply Challenges

The UK has experienced intermittent Wegovy supply constraints since its initial launch, with certain dose strengths periodically unavailable through traditional pharmacy channels. At Cured Pharmacy, we've established reliable supply partnerships with UK-licensed wholesalers to maintain consistent stock across all five Wegovy dose strengths — 0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg.

This complete dose availability is critical for treatment continuity. Patients forced to pause their dose escalation or interrupt maintenance therapy due to stock shortages often experience weight regain and renewed side effects when restarting [2]. Our inventory management system prioritises existing patients to prevent treatment interruptions whilst accommodating new starters on the 0.25mg initiation dose.

Every Wegovy pen we dispense is sourced exclusively from MHRA-licensed UK wholesalers, stored in temperature-controlled pharmaceutical refrigeration at 2-8°C, and shipped in validated cold-chain packaging to maintain product integrity throughout transit. You'll receive detailed storage instructions with every delivery, as Wegovy must be refrigerated until use but can be stored at room temperature (up to 30°C) for up to 28 days if needed [2].

Clinical Efficacy: What the STEP Trials Revealed

The STEP clinical trial programme represents the most comprehensive investigation of semaglutide 2.4mg for weight management, encompassing over 4,500 participants across multiple international sites. STEP 1, the pivotal registration trial, demonstrated that 86.4% of participants on semaglutide achieved at least 5% weight loss — the threshold NICE considers clinically meaningful — compared to 31.5% on placebo [1].

More impressively, nearly one-third of semaglutide participants achieved ≥20% body weight reduction, a magnitude previously only observed with bariatric surgery. These results were sustained through 68 weeks of treatment, with accompanying improvements in waist circumference, blood pressure, lipid profiles, and glycaemic control markers even in participants without diabetes [1].

The STEP 4 withdrawal trial provided crucial evidence about treatment duration. Participants who discontinued semaglutide after 20 weeks regained approximately two-thirds of their lost weight over the subsequent 48 weeks, whilst those continuing treatment maintained their weight reduction [4]. This data supports ongoing treatment rather than short-term courses, subject to continued clinical benefit and tolerability.

Real-World Outcomes Beyond Clinical Trials

Post-marketing surveillance and real-world evidence studies conducted through UK primary care databases have largely confirmed trial findings, though average weight loss in routine practice tends to be modestly lower — typically 10-12% — reflecting the challenges of maintaining lifestyle modifications outside controlled trial environments [3]. Our clinical team at Cured Pharmacy provides ongoing support resources to help bridge this efficacy gap between trial conditions and real-world use.

Managing Wegovy Side Effects: A Pharmacist's Perspective

Gastrointestinal side effects — particularly nausea, diarrhoea, vomiting, and constipation — affect the majority of Wegovy users during initial treatment phases, though severity typically diminishes over 4-8 weeks as your body adapts to each new dose [2]. These effects result directly from semaglutide's mechanism of slowing gastric emptying and are generally more pronounced after dose escalations.

From dispensing thousands of Wegovy prescriptions, I've observed that patients who implement specific dietary modifications experience significantly better tolerability. Eating smaller, more frequent meals rather than large portions, avoiding high-fat foods that delay gastric emptying further, and staying well-hydrated throughout the day can substantially reduce nausea severity. Taking your injection in the evening rather than morning may also help, as peak drug levels occur 1-3 days post-injection when side effects are typically worst.

More serious but rare adverse effects include pancreatitis (severe persistent abdominal pain radiating to the back), gallbladder disease, and acute kidney injury secondary to severe dehydration from vomiting or diarrhoea [2]. If you experience persistent severe abdominal pain, reduced urination, or inability to keep fluids down for more than 24 hours, discontinue Wegovy and seek immediate medical attention. Our clinical team is available on (+44) 116 4646009 during business hours for side effect consultations.

Buy Wegovy Online UK: The Cured Pharmacy Process

Wegovy is a prescription-only medicine in the UK, meaning you cannot legally purchase it without a valid prescription from a UK-registered prescriber. At Cured Pharmacy, we've streamlined this process into a clinically robust yet convenient pathway that typically takes under 10 minutes from assessment to prescription approval.

Start by completing our online clinical questionnaire, which gathers your medical history, current medications, weight management goals, and contraindication screening. This assessment is reviewed by our UK-registered prescribing clinicians — never automated algorithms — who determine whether Wegovy is clinically appropriate and safe for you based on NICE and MHRA guidance. If approved, your prescription is issued electronically and sent directly to our dispensary.

We dispense your Wegovy pens the same day for orders placed before 3pm on weekdays, with discreet next-day delivery via tracked courier in temperature-controlled packaging. You'll receive injection technique guidance, a sharps disposal container, and 24/7 access to our clinical support team for any questions during your treatment journey. Pricing remains transparent at £79.00 with no hidden consultation fees or subscription charges — you see the full cost before completing your assessment.

Ongoing Prescription Management

Wegovy requires ongoing prescriptions as you progress through dose escalations and maintenance therapy. Our system automatically reminds you when your next prescription is due based on your dosing schedule, and follow-up assessments take just 2-3 minutes to update your progress and confirm continued suitability. This ensures uninterrupted treatment without the need for repeated GP appointments, whilst maintaining full clinical oversight by UK-registered healthcare professionals throughout your weight loss journey.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
2. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/13799
3. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. Retrieved from https://www.nice.org.uk/guidance/ta875
4. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.